Evidence map›Paper›PMID 41932854›Full record

ArticleJournal of applied clinical medical physics2026

Assessing inter-observer variability in prostate and GTV segmentation on mpMRI: A comparison between radiation oncologists and AI-based method.

Philippe Dionne, André-Guy Martin, Étienne Ouellet, Jean-Christophe Roy, Ingrid Sidibé, Marie-Anne Froment, Éric Vigneault, William Foster, François Bachand, Louis Archambault and 1 more

Abstract readComparative Study
In one paragraph

Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Philippe DionneDépartement de physique, génie physique et d'optique, Faculté des sciences et de génie, Université Laval, Québec, Canada.ORCID https://orcid.org/0009-0000-2047-1545
André-Guy MartinService de radio-oncologie, CHU de Québec - Université Laval, Québec, Canada.ORCID https://orcid.org/0000-0003-4214-9148
Étienne OuelletAxe Oncologie, Centre de recherche du CHU de Québec - Université Laval, Québec, Canada.ORCID https://orcid.org/0000-0002-8361-538X
Jean-Christophe RoyAxe Oncologie, Centre de recherche du CHU de Québec - Université Laval, Québec, Canada.
Ingrid SidibéService de radio-oncologie, CHU de Québec - Université Laval, Québec, Canada.
Marie-Anne FromentService de radio-oncologie, CHU de Québec - Université Laval, Québec, Canada.
Éric VigneaultService de radio-oncologie, CHU de Québec - Université Laval, Québec, Canada.ORCID https://orcid.org/0000-0002-7201-9400
William FosterService de radio-oncologie, CHU de Québec - Université Laval, Québec, Canada.
François BachandService de radio-oncologie, CHU de Québec - Université Laval, Québec, Canada.
Louis ArchambaultDépartement de physique, génie physique et d'optique, Faculté des sciences et de génie, Université Laval, Québec, Canada.ORCID https://orcid.org/0000-0002-6065-3113
Éric PoulinDépartement de physique, génie physique et d'optique, Faculté des sciences et de génie, Université Laval, Québec, Canada.ORCID https://orcid.org/0000-0003-2138-2063

Funding

Siemens Healthineers CanadaVarian Medical Systems, a Siemens Healthineers company
6 · The paper itself

Abstract

backgroundAccurate delineation of the prostate and intraprostatic gross tumor volume (GTV) on multiparametric MRI (mpMRI) is critical for radiation therapy planning, particularly for focal dose escalation strategies. However, interpretation of mpMRI can be challenging and prone to inter-observer variability, especially among radiation oncologists (ROs) who may have limited training in prostate MRI interpretation. In addition, because many patients do not undergo diagnostic mpMRI before treatment, radiologist input is often absent during treatment planning, which can compromise accurate GTV delineation. PURPOSE: To evaluate approaches for improving focal prostate GTV delineation on mpMRI for radiotherapy planning, by assessing the impact of radiology reports on ROs contours, and comparing the performance of an automated segmentation tool (AIRC) with radiologists' contours as a potential replacement when radiologist input is unavailable.

methodsTwenty patients underwent mpMRI at our institution. Delineation of the prostate gland and GTV was performed by ROs in two phases. In the first phase, ROs segmented both structures with access only to biopsy results, indicating positive core locations. In the second phase, they repeated the segmentation with access to the radiology report. AIRC segmented both structures as well, using the same images as made available to the ROs. Lesion detection performance was evaluated using sensitivity and positive predictive value (PPV). Segmentations were compared to consensus contours from two radiologists using the STAPLE algorithm. Similarity metrics computed included Dice similarity coefficient (DSC), Hausdorff distance (HD), distance from center, and relative volume difference.

resultsProstate gland segmentation showed minimal inter-observer variability and high agreement with the reference, with a mean DSC of

conclusionsHigh inter-observer variability in GTV segmentation was observed when ROs lacked access to the radiology report, underscoring the difficulty of mpMRI interpretation. Providing radiology reports and establishing standardized guidelines for mpMRI interpretation may improve segmentation accuracy and consistency. An Automated segmentation tool could facilitate the first step in the planning workflow by assisting ROs in target definition.

Indexed as

Artificial IntelligenceImage Processing, Computer-AssistedMultiparametric Magnetic Resonance ImagingProstatic NeoplasmsRadiation OncologistsRadiotherapy Planning, Computer-AssistedAlgorithmsHumansMaleObserver VariationPrognosisRadiotherapy DosageRadiotherapy, Intensity-ModulatedTumor BurdenmpMRIprostate cancersegmentation

Identifiers

PMID41932854
PMCPMC13052058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.